Famciclovir

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 42291-415
  • Package NDC 42291-415-30
  • Application number ANDA077487
  • SPL ID 485cfe40-2ff0-e83f-e063-6394a90a221c
  • SPL set ID c2b21ad5-fa83-1fb6-e053-2a95a90a3d0f
  • UNII QIC03ANI02
  • RxCUI 198382
  • RxCUI 199192
  • RxCUI 199193

What the source publishes

Labeler
AvKARE
Active ingredients
Famciclovir
Form
TABLET, FILM COATED
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:42291-415_485cfe40-2ff0-e83f-e063-6394a90a221c
{
  "name": "Famciclovir",
  "splId": "485cfe40-2ff0-e83f-e063-6394a90a221c",
  "labels": [
    {
      "setId": "c2b21ad5-fa83-1fb6-e053-2a95a90a3d0f",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c2b21ad5-fa83-1fb6-e053-2a95a90a3d0f",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c2b21ad5-fa83-1fb6-e053-2a95a90a3d0f"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "AvKARE",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET, FILM COATED in 1 BOTTLE (42291-415-30)",
      "package_ndc": "42291-415-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20210519"
    }
  ],
  "productId": "42291-415_485cfe40-2ff0-e83f-e063-6394a90a221c",
  "useDomain": "unknown",
  "dosageForm": "TABLET, FILM COATED",
  "productNdc": "42291-415",
  "deaSchedule": null,
  "genericName": "Famciclovir",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "FAMCICLOVIR",
      "strength": "250 mg/1"
    }
  ],
  "applicationNumber": "ANDA077487",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20210519",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000020060",
      "N0000180187",
      "N0000175459"
    ],
    "unii": [
      "QIC03ANI02"
    ],
    "rxcui": [
      "198382",
      "199192",
      "199193"
    ],
    "spl_set_id": [
      "c2b21ad5-fa83-1fb6-e053-2a95a90a3d0f"
    ],
    "pharm_class_epc": [
      "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "DNA Polymerase Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "AvKARE"
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:42291-415_485cfe40-2ff0-e83f-e063-6394a90a221c"